Line Bjørge
Haukeland University Hospital(NO)University of Bergen(NO)
Publications by Year
Research Areas
Ovarian cancer diagnosis and treatment, Endometrial and Cervical Cancer Treatments, Pregnancy and preeclampsia studies, PARP inhibition in cancer therapy, Cancer-related molecular mechanisms research
Most-Cited Works
- → Common Genetic Variation In Cellular Transport Genes and Epithelial Ovarian Cancer (EOC) Risk(2015)906 cited
- → Landscape of genomic alterations in cervical carcinomas(2013)870 cited
- → Niraparib plus bevacizumab versus niraparib alone for platinum-sensitive recurrent ovarian cancer (NSGO-AVANOVA2/ENGOT-ov24): a randomised, phase 2, superiority trial(2019)243 cited
- → Standard first-line chemotherapy with or without nintedanib for advanced ovarian cancer (AGO-OVAR 12): a randomised, double-blind, placebo-controlled phase 3 trial(2015)208 cited
- → The genomic landscape and evolution of endometrial carcinoma progression and abdominopelvic metastasis(2016)204 cited
- → Atezolizumab plus bevacizumab and chemotherapy for metastatic, persistent, or recurrent cervical cancer (BEATcc): a randomised, open-label, phase 3 trial(2023)184 cited